Kurt Graves

Mr. Kurt C.
Graves is a Chairman, President & Chief Executive Officer at I2o Therapeutics, Inc. and an Independent Director at Seres Therapeutics, Inc. He is on the Board of Directors at Seres Therapeutics, Inc. and Alevium Pharmaceuticals, Inc. Mr. Graves was previously employed as an Independent Director by Achillion Pharmaceuticals, Inc., a Chairman by Radius Health, Inc., an Executive Chairman by Biolex Therapeutics, Inc., a Chairman, President & Chief Executive Officer by Intarcia Therapeutics, Inc., a Chief Commercial Officer & Executive VP by Vertex Pharmaceuticals, Inc., a Chief Marketing Officer-Pharmaceuticals Division by Novartis Pharmaceuticals Corp., an Executive Director by Astra Merck, Inc., and a Product Manager by Merck & Co., Inc. He also served on the board at Pulmatrix Operating Co., Inc., Pulmatrix, Inc. and SpringLeaf Therapeutics, Inc. He received his undergraduate degree from Hillsdale College.